Arvinas Competitors and Similar CompaniesClear all

Arvinas's competitors and similar companies include NextCure.

	Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Type	Type Public	Type Public
Tags	Tags Healthcare Technology drug development oncology pharma platform therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy
Locations	Locations New Haven, US HQ	Locations Beltsville, US HQ
Employees	Employees 13329% increase	Employees N/A
Valuation ($)	Valuation ($) 1.9 b	Valuation ($) 39.2 m
Financial
Net income	Net income ($80.8m) (FY, 2025)	Net income ($55.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 111.6m	Total funding raised $ 160m

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

Financial